Vimta Labs Limited (BOM:524394)
571.95
+5.35 (0.94%)
At close: Jun 19, 2026
Vimta Labs Revenue
In the fiscal year ending March 31, 2026, Vimta Labs had annual revenue of 4.10B INR with 18.62% growth. Vimta Labs had revenue of 1.12B in the quarter ending March 31, 2026, with 16.48% growth.
Revenue
4.10B
Revenue Growth
+18.62%
P/S Ratio
6.24
Revenue / Employee
2.96M
Employees
1,384
Market Cap
25.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.10B | 643.01M | 18.62% |
| Mar 31, 2025 | 3.45B | 557.57M | 19.25% |
| Mar 31, 2024 | 2.90B | -294.23M | -9.22% |
| Mar 31, 2023 | 3.19B | 402.99M | 14.46% |
| Mar 31, 2022 | 2.79B | 677.23M | 32.09% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jain Irrigation Systems | 64.00B |
| Prakash Industries | 34.79B |
| Insolation Energy | 21.46B |
| Federal-Mogul Goetze (India) | 19.58B |
| Hikal | 17.13B |
| HLE Glascoat | 13.53B |
| Kiri Industries | 8.40B |
| Kilburn Engineering | 6.29B |
Vimta Labs News
- 22 days ago - Vimta Labs Transcript: Q4 25/26 - Transcripts
- 22 days ago - Vimta Labs Quarterly report: Q4 2026 - Filings
- 22 days ago - Vimta Labs Slides: Q4 2026 - Filings
- 22 days ago - Vimta Labs Annual report: Q4 2026 - Filings
- 5 months ago - Vimta Labs Transcript: Q3 25/26 - Transcripts
- 5 months ago - Vimta Labs Quarterly report: Q3 2026 - Filings
- 5 months ago - Vimta Labs Slides: Q3 2026 - Filings
- 8 months ago - Vimta Labs Transcript: Q2 25/26 - Transcripts